Thrombocytopenia 4
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Thrombocytopenia 4
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Thrombocytopenia
|
0.650 |
Biomarker
|
phenotype |
HPO |
|
|
|
Choriocarcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Chorionic somatomammotropin (hCS) genes (hCS-A and hCS-B) and the placental growth hormone variant (hGH-V) gene are expressed in the syncytiotrophoblast in vivo, and at low levels in cytotrophoblast-like choriocarcinoma (BeWo) cells.
|
8472847 |
1993 |
Chondrosarcoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
HCS-2/8 is a stable human chondrosarcoma cell line with many chondrocytic characteristics and has the capacity to form chondrosarcomas in nude mice.
|
8200849 |
1994 |
Choriocarcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We demonstrated that TEF-1 represses hCS promoter activity in choriocarcinoma (BeWo) cells (Jiang, S.W., and Eberhardt, N.L.(1995) J. Biol.Chem.
|
8621623 |
1996 |
Choriocarcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Each individual concatenated enhanson was able to stimulate hCS promoter activity in an orientation-independent manner in choriocarcinoma cells (BeWo) with an observed stimulation that was directly proportional to its relative binding affinity for TEF-1 and CSEF-1.
|
9259314 |
1997 |
Fatty Liver
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mitochondrial adaptations to obesity-related oxidant stress.
|
10860543 |
2000 |
Steatohepatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mitochondrial adaptations to obesity-related oxidant stress.
|
10860543 |
2000 |
Blood Platelet Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
This study of a family with the platelet disorder characterized by a defect of the platelet P2(CYC) receptor supports our hypothesis that the full complement of the platelet ADP receptors is essential for normal platelet secretion and that some patients with the common, ill-defined diagnosis of PSD are actually heterozygous for the defect.
|
11073862 |
2000 |
Transient Ischemic Attack
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Posterior Circulation Transient Ischemic Attack
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Carotid Circulation Transient Ischemic Attack
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Transient Ischemic Attack, Vertebrobasilar Circulation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Crescendo Transient Ischemic Attacks
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Brain Stem Ischemia, Transient
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Transient Cerebral Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Transient Ischemic Attack, Anterior Circulation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice.
|
11333366 |
2001 |
Chondrosarcoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Cell density-dependent proliferative effects of transforming growth factor (TGF)-beta 1, beta 2, and beta 3 in human chondrosarcoma cells HCS-2/8 are associated with changes in the expression of TGF-beta receptor type I.
|
11458815 |
2001 |
Brain Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation.
|
11756504 |
2002 |
Cerebral Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation.
|
11756504 |
2002 |
Ischemia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury.
|
15172883 |
2004 |
Chondrosarcoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
New clonal-cell lines HCS-TG C3 and E2 derived from human chondrosarcoma are morphologically chondrocytic in serial monolayer cultures and express chondrocytic phenotypes.
|
15118855 |
2004 |
Obesity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice.
|
16317704 |
2005 |
Hyperthymic state
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
PCAs showed the presence of a global major factor for each clinician-rated subscale with respective eigenvalues of the correlation matrices as follows: 7.1 for HYP-T, 6.0 for DEP-T, and 4.7 for CYC-T.
|
15780673 |
2005 |